Safety of Testosterone-Replacement Therapy in Older Men
New England Journal of Medicine · 13.07.2023 · 389 (2) · 177-178
DOI: 10.1056/nejme2305946 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 13.07.2023. Verfasst von Eric Orwoll. Beteiligte Einrichtung: From Oregon Health and Science University, Portland. Hauptthemen laut MEDLINE: Testosterone, Hormone Replacement Therapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Circulating levels of testosterone decline with age in men,1 and some clinical consequences of hypogonadism resemble those of normal aging: fatigue, weakness, and impaired sexual function. These outcomes have led to the reasonable hypothesis that age-related decreases in testosterone levels may cause these symptoms and that quality of life could be improved by testosterone supplementation. Although the number of older men with testosterone levels below the normal range is small,2 the past several decades have seen large increases in the number of prescriptions for testosterone, mainly for middle-aged and older men.3 Despite the large number of men receiving testosterone supplementation, . . .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Oregon Health and Science University, Portland.
Zitieren
APA
Orwoll, E. (2023). Safety of Testosterone-Replacement Therapy in Older Men. New England Journal of Medicine, 389(2), 177-178. https://doi.org/10.1056/nejme2305946
Vancouver
Orwoll E. Safety of Testosterone-Replacement Therapy in Older Men. New England Journal of Medicine. 2023;389(2):177-178. doi:10.1056/nejme2305946
BibTeX
@article{Orwoll2023,
author = {Orwoll, Eric},
title = {Safety of Testosterone-Replacement Therapy in Older Men},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {2},
pages = {177--178},
doi = {10.1056/nejme2305946}
}
EUVIMED